메뉴 건너뛰기




Volumn 67, Issue 19, 2007, Pages 9089-9096

Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; HOMEODOMAIN PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN NKX3.1; TESTOSTERONE; UNCLASSIFIED DRUG;

EID: 35148851505     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2887     Document Type: Article
Times cited : (74)

References (33)
  • 1
    • 0023395389 scopus 로고
    • The endocrinology and developmental biology of the prostate
    • Cunha GR, Donjacour AA, Cooke PS, et al. The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8:338-62.
    • (1987) Endocr Rev , vol.8 , pp. 338-362
    • Cunha, G.R.1    Donjacour, A.A.2    Cooke, P.S.3
  • 2
    • 0036645414 scopus 로고    scopus 로고
    • Molecular biology of the androgen receptor
    • Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol 2002;20:3001-15.
    • (2002) J Clin Oncol , vol.20 , pp. 3001-3015
    • Gelmann, E.P.1
  • 3
    • 9644279380 scopus 로고    scopus 로고
    • Androgen deprivation therapy for prostate cancer: Current status and future prospects
    • Miyamoto H, Messing EM, Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate 2004;61:332-53.
    • (2004) Prostate , vol.61 , pp. 332-353
    • Miyamoto, H.1    Messing, E.M.2    Chang, C.3
  • 4
    • 84928580276 scopus 로고
    • The effect of castration, of estrogens, and of androgen injection on serum phosphatase in metastatic carcinoma of prostate
    • Huggins C, Hodges CV. The effect of castration, of estrogens, and of androgen injection on serum phosphatase in metastatic carcinoma of prostate. Cancer Res 1941;1:293-7.
    • (1941) Cancer Res , vol.1 , pp. 293-297
    • Huggins, C.1    Hodges, C.V.2
  • 5
    • 35148846249 scopus 로고    scopus 로고
    • Androgen deprivation therapy: A cornerstone in the treatment of advanced prostate cancer
    • Brawer MK. Androgen deprivation therapy: a cornerstone in the treatment of advanced prostate cancer. Rev Urol 2004;6 Suppl 8:S3-9.
    • (2004) Rev Urol , vol.6 , Issue.SUPPL. 8
    • Brawer, M.K.1
  • 6
    • 35148857911 scopus 로고    scopus 로고
    • Hormonal therapy in prostate cancer: Historical approaches
    • Crawford ED. Hormonal therapy in prostate cancer: historical approaches. Rev Urol 2004;6 Suppl 7:S3-11.
    • (2004) Rev Urol , vol.6 , Issue.SUPPL. 7
    • Crawford, E.D.1
  • 7
    • 35148817305 scopus 로고    scopus 로고
    • Androgen deprivation therapy in the treatment of advanced prostate cancer
    • Perlmutter MA, Lepor H. Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol 2007;9 Suppl 1:S3-8.
    • (2007) Rev Urol , vol.9 , Issue.SUPPL. 1
    • Perlmutter, M.A.1    Lepor, H.2
  • 8
    • 20344408318 scopus 로고    scopus 로고
    • Future directions in the treatment of androgen-independent prostate cancer
    • Petrylak DP. Future directions in the treatment of androgen-independent prostate cancer. Urology 2005;65:8-12.
    • (2005) Urology , vol.65 , pp. 8-12
    • Petrylak, D.P.1
  • 9
    • 0033660592 scopus 로고    scopus 로고
    • The role of steroid hormones in prostate carcinogenesis
    • Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000;27:39-66.
    • (2000) J Natl Cancer Inst Monogr , vol.27 , pp. 39-66
    • Bosland, M.C.1
  • 10
    • 33847779665 scopus 로고    scopus 로고
    • Sex steroids and prostate carcinogenesis: Integrated, multifactorial working hypothesis
    • Bosland MC. Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis. Ann N Y Acad Sci 2006;1089:168-76.
    • (2006) Ann N Y Acad Sci , vol.1089 , pp. 168-176
    • Bosland, M.C.1
  • 11
    • 0029688899 scopus 로고    scopus 로고
    • Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models
    • Bosland MC. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog Clin Biol Res 1996;394:309-52.
    • (1996) Prog Clin Biol Res , vol.394 , pp. 309-352
    • Bosland, M.C.1
  • 12
    • 0036185247 scopus 로고    scopus 로고
    • Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer
    • Furuya Y, Nozaki T, Nagakawa O, Fuse H. Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer. Endocr J 2002;49:85-90.
    • (2002) Endocr J , vol.49 , pp. 85-90
    • Furuya, Y.1    Nozaki, T.2    Nagakawa, O.3    Fuse, H.4
  • 13
    • 0344406150 scopus 로고    scopus 로고
    • Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
    • Massengill JC, Sun L, Moul JW, et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 2003;169:1670-5.
    • (2003) J Urol , vol.169 , pp. 1670-1675
    • Massengill, J.C.1    Sun, L.2    Moul, J.W.3
  • 14
    • 13844299328 scopus 로고    scopus 로고
    • Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy
    • Imamoto T, Suzuki H, Fukasawa S, et al. Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Eur Urol 2005;47:308-12.
    • (2005) Eur Urol , vol.47 , pp. 308-312
    • Imamoto, T.1    Suzuki, H.2    Fukasawa, S.3
  • 15
    • 0030690915 scopus 로고    scopus 로고
    • Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer
    • Ribeiro M, Ruff P, Falkson G. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am J Clin Oncol 1997;20:605-8.
    • (1997) Am J Clin Oncol , vol.20 , pp. 605-608
    • Ribeiro, M.1    Ruff, P.2    Falkson, G.3
  • 16
    • 0033950926 scopus 로고    scopus 로고
    • Is low serum free testosterone a marker for high grade prostate cancer?
    • Hoffman MA, DeWolf WC, Morgentaler A. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000;163:824-7.
    • (2000) J Urol , vol.163 , pp. 824-827
    • Hoffman, M.A.1    DeWolf, W.C.2    Morgentaler, A.3
  • 17
    • 27644452640 scopus 로고    scopus 로고
    • Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
    • Titus MA, Schell MJ, Lih FB, Tomer KB, Mohler JL. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 2005;11:4653-7.
    • (2005) Clin Cancer Res , vol.11 , pp. 4653-4657
    • Titus, M.A.1    Schell, M.J.2    Lih, F.B.3    Tomer, K.B.4    Mohler, J.L.5
  • 18
    • 0034681264 scopus 로고    scopus 로고
    • The multiple roles of PTEN in tumor suppression
    • Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000;100:387-90.
    • (2000) Cell , vol.100 , pp. 387-390
    • Di Cristofano, A.1    Pandolfi, P.P.2
  • 19
    • 30944461586 scopus 로고    scopus 로고
    • PTEN and GSK3h: Key regulators of progression to androgen-independent prostate cancer
    • Mulholland DJ, Dedhar S, Wu H, Nelson CC. PTEN and GSK3h: key regulators of progression to androgen-independent prostate cancer. Oncogene 2006;25:329-37.
    • (2006) Oncogene , vol.25 , pp. 329-337
    • Mulholland, D.J.1    Dedhar, S.2    Wu, H.3    Nelson, C.C.4
  • 20
    • 0038335334 scopus 로고    scopus 로고
    • PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling
    • Paez J, Sellers WR. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 2003;115:145-67.
    • (2003) Cancer Treat Res , vol.115 , pp. 145-167
    • Paez, J.1    Sellers, W.R.2
  • 21
    • 0344737828 scopus 로고    scopus 로고
    • Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis
    • Shen MM, Abate-Shen C. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 2003;228:767-78.
    • (2003) Dev Dyn , vol.228 , pp. 767-778
    • Shen, M.M.1    Abate-Shen, C.2
  • 22
    • 0035740250 scopus 로고    scopus 로고
    • Chromosomal deletions and tumor suppressor genes in prostate cancer
    • Dong JT. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001;20:173-93.
    • (2001) Cancer Metastasis Rev , vol.20 , pp. 173-193
    • Dong, J.T.1
  • 23
    • 0043244937 scopus 로고    scopus 로고
    • Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases
    • Abate-Shen C, Banach-Petrosky WA, Sun X, et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res 2003;63:3886-90.
    • (2003) Cancer Res , vol.63 , pp. 3886-3890
    • Abate-Shen, C.1    Banach-Petrosky, W.A.2    Sun, X.3
  • 24
    • 33749254070 scopus 로고    scopus 로고
    • Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
    • Gao H, Ouyang X, Banach-Petrosky WA, Gerald WL, Shen MM, Abate-Shen C. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A 2006;103:14477-82.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 14477-14482
    • Gao, H.1    Ouyang, X.2    Banach-Petrosky, W.A.3    Gerald, W.L.4    Shen, M.M.5    Abate-Shen, C.6
  • 25
    • 0037022663 scopus 로고    scopus 로고
    • Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
    • Kim MJ, Cardiff RD, Desai N, et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A 2002;99:2884-9.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 2884-2889
    • Kim, M.J.1    Cardiff, R.D.2    Desai, N.3
  • 26
    • 33748038440 scopus 로고    scopus 로고
    • Emergence of androgen independence at early stages of prostate cancer progression in nkx3.1; pten mice
    • Gao H, Ouyang X, Banach-Petrosky WA, Shen MM, Abate-Shen C. Emergence of androgen independence at early stages of prostate cancer progression in nkx3.1; pten mice. Cancer Res 2006;66:7929-33.
    • (2006) Cancer Res , vol.66 , pp. 7929-7933
    • Gao, H.1    Ouyang, X.2    Banach-Petrosky, W.A.3    Shen, M.M.4    Abate-Shen, C.5
  • 27
    • 0036966275 scopus 로고    scopus 로고
    • Prostatic intraepithelial neoplasia in genetically engineered mice
    • Park JH, Walls JE, Galvez JJ, et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 2002;161:727-35.
    • (2002) Am J Pathol , vol.161 , pp. 727-735
    • Park, J.H.1    Walls, J.E.2    Galvez, J.J.3
  • 28
    • 0142121516 scopus 로고    scopus 로고
    • Exploration, normalization, and summaries of high density oligonucleotide array probe level data
    • Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
    • (2003) Biostatistics , vol.4 , pp. 249-264
    • Irizarry, R.A.1    Hobbs, B.2    Collin, F.3
  • 29
    • 0035829361 scopus 로고    scopus 로고
    • Controlling the false discovery rate in behavior genetics research
    • Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-84.
    • (2001) Behav Brain Res , vol.125 , pp. 279-284
    • Benjamini, Y.1    Drai, D.2    Elmer, G.3    Kafkafi, N.4    Golani, I.5
  • 30
    • 30044434221 scopus 로고    scopus 로고
    • RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region
    • Fowler M, Borazanci E, McGhee L, et al. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem 2006;97:1-17.
    • (2006) J Cell Biochem , vol.97 , pp. 1-17
    • Fowler, M.1    Borazanci, E.2    McGhee, L.3
  • 31
    • 33746512473 scopus 로고    scopus 로고
    • Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity
    • Lyons LS, Burnstein KL. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity. Mol Endocrinol 2006;20:1061-72.
    • (2006) Mol Endocrinol , vol.20 , pp. 1061-1072
    • Lyons, L.S.1    Burnstein, K.L.2
  • 32
    • 1842612441 scopus 로고    scopus 로고
    • Molecular determinants of resistance to antiandrogen therapy
    • Chen CD, Welsbie DS, Tran C, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004;10:33-9.
    • (2004) Nat Med , vol.10 , pp. 33-39
    • Chen, C.D.1    Welsbie, D.S.2    Tran, C.3
  • 33
    • 0037812658 scopus 로고    scopus 로고
    • The influence of finasteride on the development of prostate cancer
    • Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24.
    • (2003) N Engl J Med , vol.349 , pp. 215-224
    • Thompson, I.M.1    Goodman, P.J.2    Tangen, C.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.